EP0321497A1 - Peptides inhibiteurs de la rennine presentant des parties nouvelles a terminaison en c - Google Patents

Peptides inhibiteurs de la rennine presentant des parties nouvelles a terminaison en c

Info

Publication number
EP0321497A1
EP0321497A1 EP87906262A EP87906262A EP0321497A1 EP 0321497 A1 EP0321497 A1 EP 0321497A1 EP 87906262 A EP87906262 A EP 87906262A EP 87906262 A EP87906262 A EP 87906262A EP 0321497 A1 EP0321497 A1 EP 0321497A1
Authority
EP
European Patent Office
Prior art keywords
amino
hydroxy
alkyl
aryl
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP87906262A
Other languages
German (de)
English (en)
Inventor
Heinrich J. Schostarez
Jackson B. Hester, Jr.
Tomi K. Sawyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of EP0321497A1 publication Critical patent/EP0321497A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

Nouveaux peptides inhibiteurs de la rennine, de formule (I): X-A6-B7-C8-D9-E10-F11-V, et plus particulièrement peptides présentant la formule (I) dans laquelle A6, B7, C8 et D9 peuvent représenter un reste d'acide aminé, E10 et F11 peuvent représenter le diamino-1,4 3-hydroxybutane disubstitué ou une autre partie stable de transition; X est un groupe terminal et V est un groupe terminal nouveau. De tels inhibiteurs sont utiles pour le diagnostic et le traitement de l'hypertension liée à la rennine.
EP87906262A 1986-09-30 1987-09-10 Peptides inhibiteurs de la rennine presentant des parties nouvelles a terminaison en c Withdrawn EP0321497A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US91349086A 1986-09-30 1986-09-30
US913490 1986-09-30
US92583086A 1986-10-30 1986-10-30
US925830 1986-10-30
US707987A 1987-01-27 1987-01-27
US7079 1987-01-27

Publications (1)

Publication Number Publication Date
EP0321497A1 true EP0321497A1 (fr) 1989-06-28

Family

ID=27358265

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87906262A Withdrawn EP0321497A1 (fr) 1986-09-30 1987-09-10 Peptides inhibiteurs de la rennine presentant des parties nouvelles a terminaison en c

Country Status (5)

Country Link
EP (1) EP0321497A1 (fr)
JP (1) JPH02500025A (fr)
AU (1) AU7968687A (fr)
DK (1) DK290588D0 (fr)
WO (1) WO1988002374A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619222B2 (en) * 1987-10-21 1992-01-23 Upjohn Company, The Renin inhibitors containing a (1-amino-2-hydroxy-2- heterocyclic)ethyl moiety
DE3814325A1 (de) * 1988-04-28 1989-11-09 Merck Patent Gmbh Aminosaeurederivate
SE8802428D0 (sv) * 1988-06-28 1988-06-28 Haessle Ab New compounds
AU4035189A (en) * 1988-08-19 1990-03-23 Upjohn Company, The Renin inhibitory peptides containing suleptanic acid or derivatives thereof
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
US5539122A (en) * 1989-05-23 1996-07-23 Abbott Laboratories Retroviral protease inhibiting compounds
US5354866A (en) * 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
US5554783A (en) * 1989-05-23 1996-09-10 Abbott Laboratories Retroviral protease inhibiting compounds
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
TW217410B (fr) * 1992-04-01 1993-12-11 Ciba Geigy
DK0727419T3 (da) 1992-12-29 2002-06-10 Abbott Lab Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease
US5491253A (en) * 1993-10-22 1996-02-13 Abbott Laboratories Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
US5786500A (en) * 1993-10-22 1998-07-28 Abbott Laboratories Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ATE220661T1 (de) * 1994-10-19 2002-08-15 Novartis Erfind Verwalt Gmbh Antivirale ether von aspartat-protease-substrat- isosteren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
EP0163237A3 (fr) * 1984-05-29 1988-04-27 Merck & Co. Inc. Inhibiteurs di- et tri-peptidiques de la rénine
EP0486478A3 (en) * 1984-08-06 1992-08-12 The Upjohn Company Renin-inhibiting peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8802374A2 *

Also Published As

Publication number Publication date
DK290588A (da) 1988-05-27
AU7968687A (en) 1988-04-21
WO1988002374A2 (fr) 1988-04-07
DK290588D0 (da) 1988-05-27
WO1988002374A3 (fr) 1988-08-11
JPH02500025A (ja) 1990-01-11

Similar Documents

Publication Publication Date Title
US5132400A (en) Peptides containing a (1-amino-2-hydroxy-2-heterocyclic)ethyl moiety
WO1992003472A1 (fr) Peptides contenant des amino-polyols utilises comme mimes d'etats de transition
EP0321497A1 (fr) Peptides inhibiteurs de la rennine presentant des parties nouvelles a terminaison en c
US4663310A (en) Renin inhibitors containing 2-substituted statine
US4812442A (en) Tripeptide renin inhibitors
EP0483271B1 (fr) Peptides comprenant des diaminoglycols en tant qu'imitateurs de l'etat de transition
WO1989007109A1 (fr) Peptides inhibiteur de renine avec groupes terminaux polaires
EP0394311A1 (fr) Peptides d'inhibition de la renine contenant des acides amino et hydroxy dicarboxyliques
EP0413750A1 (fr) Peptides inhibiteurs de renine contenant un groupe phenoxyacetyle a substitution
US4839357A (en) Renin inhibitors containing phenylalanyl-histidine replacements
US5049548A (en) Renin-inhibitory di-, tri-, and tetrapeptides
WO1990012804A2 (fr) Peptides avec des groupes n-terminaux polaires
EP0278158A2 (fr) Inhibiteurs de rénine contenant des remplaçants de phénylalanyl-histidine
US4743584A (en) C-terminal amide cyclic renin inhibitors containing peptide isosteres
WO1990002137A1 (fr) Peptides inhibiteurs de la renine contenant de l'acide suleptanique ou des derives de cet acide
US5006511A (en) Di- or tripeptide renin inhibitors containing lactam conformational restriction in achpa
WO1989001488A1 (fr) Peptides inhibiteurs de la renine a liaisons non peptidiques
AU617740B2 (en) Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids
AU617740C (en) Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids
EP0349570A1 (fr) Inhibiteurs de la rennine contenant un acide amino cyclopropylique ou un cycloalkyle de transition analogue
US5039664A (en) Renin inhibitors containing phenylalanyl-histidine replacements
EP0312283A2 (fr) Inhibiteurs de la rénine di-ou tripeptidiques, contenant une restriction conformationnelle du type lactame dans ACHPA
WO1991007430A1 (fr) Peptides contenant des tripeptides cycliques
EP0366669A1 (fr) Derive d'acide malique contenant des peptides inhibant la renine
US5037807A (en) Renin inhibitors containing phenylalanyl-histidine replacements

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19890323

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19911114

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19921124